Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy

Scientific Reports ◽

10.1038/s41598-020-69965-1 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Soong June Bae ◽

Yoon Jin Cha ◽

Changik Yoon ◽

Dooreh Kim ◽

Janghee Lee ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Abstract P1-01-15: DETECT V - Detection of the expression of estrogen receptor and human epidermal growth factor receptor 2 on circulating tumor cells from metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p1-01-15 ◽

2017 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

A Schramm ◽

A Polasik ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

DETECT V – expression of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1055/s-0038-1651759 ◽

2018 ◽

Author(s):

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

FA Taran ◽

K Pantel ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial

European Journal of Cancer ◽

10.1016/j.ejca.2020.04.020 ◽

2020 ◽

Vol 134 ◽

pp. 99-106 ◽

Cited By ~ 1

Author(s):

Peter C. Dubsky ◽

Christian F. Singer ◽

Daniel Egle ◽

Viktor Wette ◽

Edgar Petru ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Response To Neoadjuvant Chemotherapy

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Hormone Receptor Positive ◽

Epidermal Growth ◽

Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer

Chinese Medical Journal ◽

10.1097/00029330-201409200-00015 ◽

2014 ◽

Vol 127 (18) ◽

pp. 3272-3277 ◽

Cited By ~ 5

Author(s):

Qin Qinghong ◽

Gao Fangfang ◽

Jiang Wei ◽

Tan Qixing ◽

Mo Qinguo ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Ki 67 ◽

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

Bulletin of Siberian Medicine ◽

10.20538/1682-0363-2020-1-13-20 ◽

2020 ◽

Vol 19 (1) ◽

pp. 13-20

Author(s):

N. N. Babyshkina ◽

T. A. Dronova ◽

E. A. Zambalova ◽

M. V. Zavyalova ◽

E. M. Slonimskaya ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Triple Negative ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Predictive factors for late (>5 years) distant recurrences in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients: >20-year follow-up.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.543 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 543-543

Author(s):

Jaskirat Singh Randhawa ◽

Sina Shafiei ◽

Mykola Onyshchenko ◽

Susmita Sakruti ◽

Rohan Garje ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Er Positive ◽

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

BMC Cancer ◽

10.1186/1471-2407-13-241 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 18

Author(s):

Mamoru Takada ◽

Toru Higuchi ◽

Katsunori Tozuka ◽

Hiroyuki Takei ◽

Masayuki Haruta ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Hormone Receptor Positive ◽

Epidermal Growth ◽

Positive Breast Cancer

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0000000000000525 ◽

2019 ◽

Vol 27 (1) ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Nosaibah Hariri ◽

Farnaz Hasteh ◽

Vighnesh Walavalkar ◽

Andres A. Roma ◽

Oluwole Fadare

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽